TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$1.77
-0.05 (-2.75%)
Open$1.83
Previous Close$1.82
Day High$1.83
Day Low$1.75
52W High$2.95
52W Low$1.11
Volume—
Avg Volume23.4K
Market Cap21.01M
P/E Ratio—
EPS$-0.02
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+571.2% upside
Current
$1.77
$1.77
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.05M | 8.69M | 4.86M |
| Net Income | -574,204 | -1,472,737 | 1.27M |
| Profit Margin | -18.8% | -17.9% | 26.2% |
| EBITDA | -4,041,603 | -10,941,928 | 2.17M |
| Free Cash Flow | — | — | 1.08M |
| Rev Growth | -64.9% | -64.9% | +8.5% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |